市場調査レポート

商品コード

1586344

ゾリンジャー・エリソン症候群治療市場、規模、シェア、動向、産業分析レポート：治療別、診断別、エンドユーザー別、地域別 - 市場予測、2024年～2032年

Zollinger-Ellison Syndrome Treatment Market Size, Share, Trends, Industry Analysis Report: By Treatment; Diagnosis; End Users; and Region - Market Forecast, 2024-2032

出版日: 2024年10月01日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,250 623,985円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 770,805円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 917,625円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Polaris Market Research社の最新調査によると、世界のゾリンジャー・エリソン症候群治療市場規模は2032年までに19億8,813万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

ゾリンジャー・エリソン症候群（ZES）治療市場は、疾患に対する認識の高まり、診断技術の進歩、標的療法の開発により急速に成長しています。ZESの有病率の上昇、ヘルスケアインフラの改善、プロトンポンプ阻害薬やソマトスタチン類似体のような新規治療薬の入手可能性といった主な要因も、市場の成長を後押ししています。

さらに、新薬製剤や併用療法の研究が進んでいることや、既存薬の適応拡大も、予測期間中に市場に有利な機会をもたらすと期待されています。また、個別化医療やデジタルヘルスソリューションの統合といった動向も、今後数年間で市場を形成すると予想されます。さらに、患者の転帰とQOLの向上への注目の高まりに後押しされ、市場は大きく拡大する構えです。

ゾリンジャー・エリソン症候群治療市場レポート・ハイライト

治療法別では、治癒の可能性がある外科的切除が市場を独占しています。しかし、新たな薬物療法や併用療法が有効性を高めていることから、化学療法分野が最も高い成長を遂げています。

エンドユーザー別では、総合的な治療と高度な診断技術を提供できる病院が市場を牽引しています。一方、専門クリニック分野は、専門的で個別化された治療オプションへの注目の高まりを反映して、最も高い成長を示しています。

北米は、先進的なヘルスケアインフラと革新的な治療の高い導入率の恩恵を受け、支配的な地域となっています。しかし、アジア太平洋地域は、新興市場におけるヘルスケア投資の増加や患者の意識の高まりを背景に、最も高い成長を見せています。

市場スナップショット
ゾリンジャー・エリソン症候群治療市場力学
- 促進要因と機会
  - 診断技術の進歩が市場の成長を牽引
  - 標的療法への注目の高まりが市場規模の拡大を牽引
- 抑制要因と課題
  - ゾリンジャー・エリソン症候群の認知度が低く、診断の課題
PESTEL分析
ゾリンジャー・エリソン症候群治療市場の動向
バリューチェーン分析
COVID-19の影響分析

第5章ゾリンジャー・エリソン症候群治療の世界市場：治療別

主な調査結果
イントロダクション
化学療法
外科的切除
その他

第6章ゾリンジャー・エリソン症候群治療の世界市場：診断別

主な調査結果
イントロダクション
血液検査
CTスキャン超音波
X線
その他

第7章ゾリンジャー・エリソン症候群治療の世界市場：エンドユーザー別

主な調査結果
イントロダクション
病院
専門クリニック
その他

第8章ゾリンジャー・エリソン症候群治療の世界市場：地域別

主な調査結果
イントロダクション
- ゾリンジャー・エリソン症候群治療市場評価：地域別、2019-2032
北米
- 北米：治療別、2019-2032
- 北米：診断別、2019-2032
- 北米：エンドユーザー別、2019-2032
- 米国
- カナダ
欧州
- 欧州：治療別、2019-2032
- 欧州：診断別、2019-2032
- 欧州：エンドユーザー別、2019-2032
- 英国
- フランス
- ドイツ
- イタリア
- スペイン
- オランダ
- ロシア
- その他欧州
アジア太平洋
- アジア太平洋地域：治療別、2019-2032
- アジア太平洋地域：診断別、2019-2032
- アジア太平洋地域：エンドユーザー別、2019-2032
- 中国
- インド
- マレーシア
- 日本
- インドネシア
- 韓国
- オーストラリア
- その他アジア太平洋地域
中東・アフリカ
- 中東・アフリカ：治療別、2019-2032
- 中東・アフリカ：診断別、2019-2032
- 中東・アフリカ：エンドユーザー別、2019-2032
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他中東とアフリカ
ラテンアメリカ
- ラテンアメリカ：治療別、2019-2032
- ラテンアメリカ：診断別、2019-2032
- ラテンアメリカ：エンドユーザー別、2019-2032
- メキシコ
- ブラジル
- アルゼンチン
- その他ラテンアメリカ

第9章競合情勢

拡大と買収の分析
- 拡大
- 買収
提携/協業/合意/公開

第10章企業プロファイル

Pfizer Inc.
Takeda Pharmaceutical Company Limited
Novartis AG
Boehringer Ingelheim International GmbH
AstraZeneca plc
GlaxoSmithKline plc
Eli Lilly and Company
Sanofi S.A.
AbbVie Inc.
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd.
Mylan N.V.
Hoffmann-La Roche Ltd.
Bristol-Myers Squibb Company

図表

List of Tables:

Table 1 Global Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 2 Global Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 3 Global Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 4 North America: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 5 North America: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 6 North America: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 7 U.S.: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 8 U.S.: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 9 U.S.: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 10 Canada: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 11 Canada: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 12 Canada: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 13 Europe: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 14 Europe: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 15 Europe: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 16 UK: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 17 UK: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 18 UK: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 19 France: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 20 France: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 21 France: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 22 Germany: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 23 Germany: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 24 Germany: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 25 Italy: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 26 Italy: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 27 Italy: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 28 Spain: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 29 Spain: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 30 Spain: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 31 Netherlands: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 32 Netherlands: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 33 Netherlands: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 34 Russia: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 35 Russia: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 36 Russia: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 37 Rest of Europe: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 38 Rest of Europe: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 39 Rest of Europe: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 40 Asia Pacific: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 41 Asia Pacific: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 42 Asia Pacific: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 43 China: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 44 China: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 45 China: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 46 India: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 47 India: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 48 India: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 49 Malaysia: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 50 Malaysia: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 51 Malaysia: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 52 Japan: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 53 Japan: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 54 Japan: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 55 Indonesia: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 56 Indonesia: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 57 Indonesia: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 58 South Korea: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 59 South Korea: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 60 South Korea: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 61 Australia: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 62 Australia: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 63 Australia: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 64 Rest of Asia Pacific: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 65 Rest of Asia Pacific: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 66 Rest of Asia Pacific: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 67 Middle East & Africa: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 68 Middle East & Africa: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 69 Middle East & Africa: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 70 Saudi Arabia: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 71 Saudi Arabia: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 72 Saudi Arabia: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 73 UAE: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 74 UAE: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 75 UAE: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 76 Israel: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 77 Israel: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 78 Israel: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 79 South Africa: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 80 South Africa: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 81 South Africa: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 82 Rest of Middle East & Africa: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 83 Rest of Middle East & Africa: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 84 Rest of Middle East & Africa: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 85 Latin America: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 86 Latin America: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 87 Latin America: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 88 Mexico: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 89 Mexico: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 90 Mexico: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 91 Brazil: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 92 Brazil: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 93 Brazil: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 94 Argentina: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 95 Argentina: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 96 Argentina: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
Table 97 Rest of Latin America: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
Table 98 Rest of Latin America: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
Table 99 Rest of Latin America: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)

List of Figures:

Figure 1. Global Zollinger-Ellison Syndrome Treatment Market, 2019-2032 (USD million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Treatment
Figure 7. Global Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2023 & 2032 (USD million)
Figure 8. Market by Diagnosis
Figure 9. Global Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2023 & 2032 (USD million)
Figure 10. Market by End User
Figure 11. Global Zollinger-Ellison Syndrome Treatment Market, by End User, 2023 & 2032 (USD million)
Figure 12. Global Zollinger-Ellison Syndrome Treatment Market Assessment, By Geography, 2019-2032 (USD million)
Figure 13. Strategic Analysis - Global Zollinger-Ellison Syndrome Treatment Market

Product Code: PM5080

The global Zollinger-Ellison syndrome treatment market size is expected to reach USD 1,988.13 million by 2032, according to a new study by Polaris Market Research. The report "Zollinger-Ellison Syndrome Treatment Market Size, Share, Trends, Industry Analysis Report: By Treatment (Chemotherapy, Surgical Resection, and Others); Diagnosis; End Users (Hospitals, Specialty Clinics, and Others); and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Zollinger-Ellison syndrome (ZES) treatment market is growing rapidly owing to increasing awareness of the disease, advancements in diagnostic technologies, and the development of targeted therapies. Key factors such as the rising prevalence of ZES, improvements in healthcare infrastructure, and the availability of novel treatments such as proton pump inhibitors and somatostatin analogs also drive the market growth.

Further, ongoing research into new drug formulations and combination therapies and expanding indications for existing medications are expected to offer lucrative opportunities for the market during the forecast period. Trends such as personalized medicine and the integration of digital health solutions are also expected to shape the market in the coming years. In addition, the market is poised for significant expansion, fueled by an increasing focus on improving patient outcomes and quality of life.

Zollinger-Ellison Syndrome Treatment Market Report Highlights

Based on treatment, the surgical resection segment dominates the market due to its potential for curative outcomes. However, the chemotherapy segment is experiencing the highest growth due to emerging drug therapies and combination treatments enhancing efficacy.

In terms of end users, the hospitals segment is leading the market, driven by their capacity to provide comprehensive care and advanced diagnostic technologies. On the other hand, the specialty clinics segment is showing the highest growth, reflecting an increasing focus on specialized and personalized treatment options.

North America is the dominant region, benefiting from advanced healthcare infrastructure and high adoption of innovative treatments. However, Asia Pacific has the highest-growing regional market, driven by increasing healthcare investments and rising patient awareness in emerging markets.

Polaris Market Research has segmented the Zollinger-Ellison syndrome treatment market report on the basis of treatment, end users, and region:

By Treatment Outlook (Revenue - USD Million, 2019-2032)

Chemotherapy

Surgical Resection

Others

By Diagnosis Outlook (Revenue - USD Million, 2019-2032)

Blood Test

CT scan Ultrasound

X-Ray

Others

By End Users Outlook (Revenue - USD Million, 2019-2032)

Hospitals

Specialty Clinics

Others

By Regional Outlook (Revenue - USD Million, 2019-2032)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Zollinger-Ellison Syndrome Treatment Market Insights

4.1. Zollinger-Ellison Syndrome Treatment Market - Market Snapshot
4.2. Zollinger-Ellison Syndrome Treatment Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Advancements in Diagnostic Technologies Are Driving Market Growth
  - 4.2.1.2. Increased Focus on Targeted Therapies is Propelling Market Size
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Limited Awareness and Diagnosis Challenges in Zollinger-Ellison Syndrome
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Zollinger-Ellison Syndrome Treatment Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Zollinger-Ellison Syndrome Treatment Market, by Treatment

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
5.3. Chemotherapy
- 5.3.1. Global Zollinger-Ellison Syndrome Treatment Market, by Chemotherapy, by Region, 2019-2032 (USD million)
5.4. Surgical Resection
- 5.4.1. Global Zollinger-Ellison Syndrome Treatment Market, by Surgical Resection, by Region, 2019-2032 (USD million)
5.5. Others
- 5.5.1. Global Zollinger-Ellison Syndrome Treatment Market, by Others, by Region, 2019-2032 (USD million)

6. Global Zollinger-Ellison Syndrome Treatment Market, by Diagnosis

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
6.3. Blood Test
- 6.3.1. Global Zollinger-Ellison Syndrome Treatment Market, by Blood Test, by Region, 2019-2032 (USD million)
6.4. CT scan Ultrasound
- 6.4.1. Global Zollinger-Ellison Syndrome Treatment Market, by CT scan Ultrasound, by Region, 2019-2032 (USD million)
6.5. X-Ray
- 6.5.1. Global Zollinger-Ellison Syndrome Treatment Market, by X-Ray, by Region, 2019-2032 (USD million)
6.6. Others
- 6.6.1. Global Zollinger-Ellison Syndrome Treatment Market, by Others, by Region, 2019-2032 (USD million)

7. Global Zollinger-Ellison Syndrome Treatment Market, by End User

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
7.3. Hospitals
- 7.3.1. Global Zollinger-Ellison Syndrome Treatment Market, by Hospitals, by Region, 2019-2032 (USD million)
  - 7.3.1.1.
7.4. Speciality Clinics
- 7.4.1. Global Zollinger-Ellison Syndrome Treatment Market, by Specialty Clinics, by Region, 2019-2032 (USD million)
7.5. Others
- 7.5.1. Global Zollinger-Ellison Syndrome Treatment Market, by Others, by Region, 2019-2032 (USD million)

8. Global Zollinger-Ellison Syndrome Treatment Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Zollinger-Ellison Syndrome Treatment Market Assessment, By Geography, 2019-2032 (USD million)
8.3. Zollinger-Ellison Syndrome Treatment Market - North America
- 8.3.1. North America: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
- 8.3.2. North America: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
- 8.3.3. North America: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.3.4. Zollinger-Ellison Syndrome Treatment Market - U.S.
  - 8.3.4.1. U.S.: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.3.4.2. U.S.: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.3.4.3. U.S.: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.3.5. Zollinger-Ellison Syndrome Treatment Market - Canada
  - 8.3.5.1. Canada: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.3.5.2. Canada: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.3.5.3. Canada: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
8.4. Zollinger-Ellison Syndrome Treatment Market - Europe
- 8.4.1. Europe: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
- 8.4.2. Europe: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
- 8.4.3. Europe: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.4.4. Zollinger-Ellison Syndrome Treatment Market - UK
  - 8.4.4.1. UK: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.4.4.2. UK: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.4.4.3. UK: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.4.5. Zollinger-Ellison Syndrome Treatment Market - France
  - 8.4.5.1. France: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.4.5.2. France: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.4.5.3. France: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.4.6. Zollinger-Ellison Syndrome Treatment Market - Germany
  - 8.4.6.1. Germany: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.4.6.2. Germany: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.4.6.3. Germany: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.4.7. Zollinger-Ellison Syndrome Treatment Market - Italy
  - 8.4.7.1. Italy: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.4.7.2. Italy: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.4.7.3. Italy: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.4.8. Zollinger-Ellison Syndrome Treatment Market - Spain
  - 8.4.8.1. Spain: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.4.8.2. Spain: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.4.8.3. Spain: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.4.9. Zollinger-Ellison Syndrome Treatment Market - Netherlands
  - 8.4.9.1. Netherlands: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.4.9.2. Netherlands: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.4.9.3. Netherlands: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.4.10. Zollinger-Ellison Syndrome Treatment Market - Russia
  - 8.4.10.1. Russia: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.4.10.2. Russia: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.4.10.3. Russia: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.4.11. Zollinger-Ellison Syndrome Treatment Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.4.11.2. Rest of Europe: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.4.11.3. Rest of Europe: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
8.5. Zollinger-Ellison Syndrome Treatment Market - Asia Pacific
- 8.5.1. Asia Pacific: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
- 8.5.2. Asia Pacific: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
- 8.5.3. Asia Pacific: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.5.4. Zollinger-Ellison Syndrome Treatment Market - China
  - 8.5.4.1. China: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.5.4.2. China: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.5.4.3. China: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.5.5. Zollinger-Ellison Syndrome Treatment Market - India
  - 8.5.5.1. India: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.5.5.2. India: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.5.5.3. India: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.5.6. Zollinger-Ellison Syndrome Treatment Market - Malaysia
  - 8.5.6.1. Malaysia: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.5.6.2. Malaysia: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.5.6.3. Malaysia: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.5.7. Zollinger-Ellison Syndrome Treatment Market - Japan
  - 8.5.7.1. Japan: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.5.7.2. Japan: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.5.7.3. Japan: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.5.8. Zollinger-Ellison Syndrome Treatment Market - Indonesia
  - 8.5.8.1. Indonesia: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.5.8.2. Indonesia: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.5.8.3. Indonesia: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.5.9. Zollinger-Ellison Syndrome Treatment Market - South Korea
  - 8.5.9.1. South Korea: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.5.9.2. South Korea: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.5.9.3. South Korea: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.5.10. Zollinger-Ellison Syndrome Treatment Market - Australia
  - 8.5.10.1. Australia: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.5.10.2. Australia: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.5.10.3. Australia: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.5.11. Zollinger-Ellison Syndrome Treatment Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.5.11.2. Rest of Asia Pacific: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.5.11.3. Rest of Asia Pacific: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
8.6. Zollinger-Ellison Syndrome Treatment Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
- 8.6.2. Middle East & Africa: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
- 8.6.3. Middle East & Africa: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.6.4. Zollinger-Ellison Syndrome Treatment Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.6.4.2. Saudi Arabia: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.6.4.3. Saudi Arabia: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.6.5. Zollinger-Ellison Syndrome Treatment Market - UAE
  - 8.6.5.1. UAE: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.6.5.2. UAE: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.6.5.3. UAE: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.6.6. Zollinger-Ellison Syndrome Treatment Market - Israel
  - 8.6.6.1. Israel: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.6.6.2. Israel: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.6.6.3. Israel: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.6.7. Zollinger-Ellison Syndrome Treatment Market - South Africa
  - 8.6.7.1. South Africa: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.6.7.2. South Africa: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.6.7.3. South Africa: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.6.8. Zollinger-Ellison Syndrome Treatment Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.6.8.2. Rest of Middle East & Africa: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.6.8.3. Rest of Middle East & Africa: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
8.7. Zollinger-Ellison Syndrome Treatment Market - Latin America
- 8.7.1. Latin America: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
- 8.7.2. Latin America: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
- 8.7.3. Latin America: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.7.4. Zollinger-Ellison Syndrome Treatment Market - Mexico
  - 8.7.4.1. Mexico: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.7.4.2. Mexico: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.7.4.3. Mexico: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.7.5. Zollinger-Ellison Syndrome Treatment Market - Brazil
  - 8.7.5.1. Brazil: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.7.5.2. Brazil: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.7.5.3. Brazil: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.7.6. Zollinger-Ellison Syndrome Treatment Market - Argentina
  - 8.7.6.1. Argentina: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.7.6.2. Argentina: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.7.6.3. Argentina: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)
- 8.7.7. Zollinger-Ellison Syndrome Treatment Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Zollinger-Ellison Syndrome Treatment Market, by Treatment, 2019-2032 (USD million)
  - 8.7.7.2. Rest of Latin America: Zollinger-Ellison Syndrome Treatment Market, by Diagnosis, 2019-2032 (USD million)
  - 8.7.7.3. Rest of Latin America: Zollinger-Ellison Syndrome Treatment Market, by End User, 2019-2032 (USD million)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Pfizer Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Takeda Pharmaceutical Company Limited
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Novartis AG
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Boehringer Ingelheim International GmbH
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. AstraZeneca plc
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. GlaxoSmithKline plc
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Eli Lilly and Company
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Sanofi S.A.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. AbbVie Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Merck & Co., Inc.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Teva Pharmaceutical Industries Ltd.
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Sun Pharmaceutical Industries Ltd.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
10.13. Mylan N.V.
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
10.14. Hoffmann-La Roche Ltd.
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
10.15. Bristol-Myers Squibb Company
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development

ゾリンジャー・エリソン症候群治療市場、規模、シェア、動向、産業分析レポート：治療別、診断別、エンドユーザー別、地域別 - 市場予測、2024年～2032年

Zollinger-Ellison Syndrome Treatment Market Size, Share, Trends, Industry Analysis Report: By Treatment; Diagnosis; End Users; and Region - Market Forecast, 2024-2032

ゾリンジャー・エリソン症候群治療市場レポート・ハイライト

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章ゾリンジャー・エリソン症候群治療の世界市場の洞察

第5章ゾリンジャー・エリソン症候群治療の世界市場：治療別

第6章ゾリンジャー・エリソン症候群治療の世界市場：診断別

第7章ゾリンジャー・エリソン症候群治療の世界市場：エンドユーザー別

第8章ゾリンジャー・エリソン症候群治療の世界市場：地域別

第9章競合情勢

第10章企業プロファイル

Zollinger-Ellison Syndrome Treatment Market Report Highlights

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Zollinger-Ellison Syndrome Treatment Market Insights

5. Global Zollinger-Ellison Syndrome Treatment Market, by Treatment

6. Global Zollinger-Ellison Syndrome Treatment Market, by Diagnosis

7. Global Zollinger-Ellison Syndrome Treatment Market, by End User

8. Global Zollinger-Ellison Syndrome Treatment Market, by Geography

9. Competitive Landscape

10. Company Profiles

ゾリンジャー・エリソン症候群治療市場、規模、シェア、動向、産業分析レポート：治療別、診断別、エンドユーザー別、地域別 - 市場予測、2024年～2032年

Zollinger-Ellison Syndrome Treatment Market Size, Share, Trends, Industry Analysis Report: By Treatment; Diagnosis; End Users; and Region - Market Forecast, 2024-2032

ゾリンジャー・エリソン症候群治療市場レポート・ハイライト

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 ゾリンジャー・エリソン症候群治療の世界市場の洞察

第5章 ゾリンジャー・エリソン症候群治療の世界市場：治療別

第6章 ゾリンジャー・エリソン症候群治療の世界市場：診断別

第7章 ゾリンジャー・エリソン症候群治療の世界市場：エンドユーザー別

第8章 ゾリンジャー・エリソン症候群治療の世界市場：地域別

第9章 競合情勢

第10章 企業プロファイル

Zollinger-Ellison Syndrome Treatment Market Report Highlights

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Zollinger-Ellison Syndrome Treatment Market Insights

5. Global Zollinger-Ellison Syndrome Treatment Market, by Treatment

6. Global Zollinger-Ellison Syndrome Treatment Market, by Diagnosis

7. Global Zollinger-Ellison Syndrome Treatment Market, by End User

8. Global Zollinger-Ellison Syndrome Treatment Market, by Geography

9. Competitive Landscape

10. Company Profiles

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章ゾリンジャー・エリソン症候群治療の世界市場の洞察

第5章ゾリンジャー・エリソン症候群治療の世界市場：治療別

第6章ゾリンジャー・エリソン症候群治療の世界市場：診断別

第7章ゾリンジャー・エリソン症候群治療の世界市場：エンドユーザー別

第8章ゾリンジャー・エリソン症候群治療の世界市場：地域別

第9章競合情勢

第10章企業プロファイル